Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium

Clinical and Experimental Ophthalmology

Volumn 33, Issue 1, 2005, Pages 60-62

  Tsai, Yi Yu ^a,b   Chang, Kong Chao ^c   Lee, Huei ^b   Cheng, Ya Wen ^b   Tsai, Fuu Jen ^a,d   Tseng, Sung Huei ^c   Ao, Hei Sio ^b   Chau, Pak Sam ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Immunohistochemistry; p53; Polymorphism; Pterygium

Indexed keywords

PROTEIN ANTIBODY; PROTEIN P53;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; EYE SURGERY; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; PTERYGIUM; STATISTICAL ANALYSIS;

AGE FACTORS; AGED; CODON; FEMALE; GENES, P53; GENOTYPE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PTERYGIUM; RNA, MESSENGER; SEX FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 14744291675     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2005.00943.x     Document Type: Article

References (15)

1. Tan DTH, Lim AS, Goh HS, Smith DR. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 1997; 123: 404-5.
2. Dushku N, Reid TW. P53 expression in altered limbal basal cells of pingula, pterygia, and limbal tumors. Curr Eye Res 1997; 16: 1179-92.
3. Onur C, Orhan D, Orhan M et al. Expression of p53 protein in pterygia. Eur J Ophthalmol 1998; 8: 157-61.
4. Chowers I, Pe'er J, Zamir E et al. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001; 108: 985-8.
5. Weinstein O, Rosenthal G, Zirkin H et al. Overexpression of p53 tumor suppressor gene in pterygia. Eye 2002; 16: 619-21.
6. Tan DTH, Tang WY, Liu YP et al. Apoptosis and apoptosis related gene expression in normal conjunctiva and pterygium. Br J Ophthalmol 2000; 84: 212-16.
7. Dushku N, Hatcher SLS, Albert DM, Reid TW. P53 expression and relation to human papillomavirus infection in pinguecula, pterygia, and limbal tumors. Arch Ophthalmol 1999; 117: 1593-9.
8. Ueda Y, Kanazawa S, Kitaoka T et al. Immunohistochemical study of p53, p21 and PCNA in pterygium. Acta Histochem 2001; 103: 159-65.
9. Henner WD, Evans AJ, Hough KM et al. Association of codon 72 polymorphism of p53 with lower prostate cancer risk. Prostate 2001; 49: 263-6.
10. Andersson S, Rylander E, Strand A et al. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. Br J Cancer 2001; 85: 1153-6.
11. Wang YC, Chen CY, Chen SK et al. P53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 1999; 5: 129-34.
12. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. P53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 2002; 179: 175-83.
13. Gottlieb TM, Oren M. P53 in growth control and neoplasia. Biochim Biophys Acta 1996; 1287: 77-102.
14. Storey A, Thomas M, Kalita A et al. Role of a p53 polymorphism in the development of human papilloma virus-associated cancer. Nature 1998; 393: 229-34.
15. Thomas M, Kalita A, Labrecque S et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999; 19: 1092-100.